Company Data
Longeveron Inc.
Ticker
LGVN
Current Price
$0.6327 -0.6%
Market Cap
$13.5M
Price Target
Refer to Report
Volume
274.0K
52wk Range
$0.5906 - $2.24
Overview
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).